Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,238.7
30.7 (0.96%)

 

  • STI Straits Times Index
    3,238.7
    30.7 (0.96%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,652.8
    14.4 (0.88%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,498.8
    271.6 (1.00%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,890.2
    2.5 (0.09%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,972.7
    -151.3 (-0.72%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,257.3
    66.8 (1.08%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,098.7
    8.0 (0.38%)
    Index delayed 20 minutes
  • XAO XAO
    6,647.9
    38.5 (0.58%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 777.7M
  • Value: 1,120.7M
  • Rise: 181
  • Fall: 119
  • Unch: 541

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
ESR-REIT0.530-0.035
Y Ventures0.137+0.035
TEE Intl0.078+0.011
NetLink NBN Tr0.880+0.010
Rex Intl0.067-
Mapletree Log Tr1.580+0.020
SingTel3.370+0.030
Synagie0.143+0.004
CapitaCom Trust2.110+0.040
Genting Sing0.885-

World Indices

World Indices
Name Last Change
Nasdaq 7,845.0 +48.4
HSI 27,498.8 +271.6
HSCEI 10,507.6 +79.1
Jakarta 6,257.3 +66.8
Nikkei 225 20,972.7 -151.3
SSE Comp 2,890.2 +2.5
Shanghai A 3,027.1 +2.7
Shanghai B 287.7 -0.1
ShenZhen A 1,573.5 +2.6
ShenZhen B 923.1 -0.3
Taiwan W 10,566.7 +36.2
PSE Comp 0.0
KOSPI 2,098.7 +8.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

QT Vascular QT VASCULAR LTD.
Quotes 10 Minutes Delayed. Updated at 18 Jun 2019 13:56
Last (SGD): 0.003 Change: - High: 0.003 Remarks: -
Change (%): - Low: 0.003
Open 0.003 Yesterday's Close 0.003
Buy Price 0.003 Sell Price 0.004
Buy Volume ('000) 14,203.0 Sell Volume ('000) 16,585.6
Cumulative Volume ('000) 1,000.0 Cumulative Value 3,000
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01801 Trailing EPS (SGD) e 0.00148 NAV (SGD) b 0.0087
PE a 0.167 Trailing PE f 2.030 Price / NAV b 0.3448
Dividend (SGD) d - Cash In Hand (SGD) g 0.0049 Issued & Paid-up Shares c 2,235,272,000
Dividend Yield (%) d - Price / Cash In Hand g 0.612 Treasury Shares h -
Beta - 75 Daysi 0.754 R-Squared - 75 Days(%)i 0.16 Market Cap (M) 6.706
Beta - 500 Daysi 0.793 R-Squared - 500 Days (%)i 0.58 Enterprise Value (M) -0.306
Piotroski F Score 4 Exchange Code 5I0 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 99.8428 6-Month VWAP 0.005 Free Float (%) 86.6
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Mining - Biotechnology
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Jun 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 6.706 0.167 2.030 0.3448 -
Industry Biotechnology SGX 1,983.583 7.325 7.675 0.6875 4.756
Medical & Biotechnology SGX 1,028.361 23.535 23.688 1.4273 1.830
Index FTSE ST Catalist Index SGX 78.962 117.554 - 0.9019 2.228
Local Peer Lonza SGX 5,937.453 7.663 7.663 0.6889 4.766
Local Peer Suntar Eco-City^ SGX 6.590 - - 0.3743 -
Global Peer AMGEN INC NASDAQ 108,806.483 12.962 13.474 10.0449 3.055
Global Peer GILEAD SCIENCES INC NASDAQ 85,321.676 15.641 14.481 3.8869 3.426
Global Peer AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Global Peer CELGENE CORP NASDAQ 68,621.798 16.960 14.462 8.4044 -
Global Peer CSL ASX 97,515.513 43.703 40.028 14.1487 1.059
Global Peer ILLUMINA INC NASDAQ 51,613.170 62.486 60.650 12.9519 -
Global Peer BIOGEN INC NASDAQ 44,940.520 10.143 9.630 3.2495 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 44,508.707 21.231 20.655 9.4232 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 34,095.334 13.948 14.045 3.6100 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 26,939.833 347.165 64.697 2.7754 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), SEATTLE GENETICS INC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE-B (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MODERNA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GENSCRIPT BIO (HKEx), 3SBIO (HKEx), TILRAY INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), REPLIGEN CORP (NASDAQ), FIBROGEN INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALKERMES PLC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), INSMED INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), GENOMIC HEALTH INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), INTREXON CORP (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ASCLETIS-B (HKEx), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HAOHAI BIOTEC (HKEx), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), HOMOLOGY MEDICINES INC (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), RETROPHIN INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), MACROGENICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ARVINAS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), VIVA BIOTECH (HKEx), TG THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), DERMIRA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ESSEX BIO-TECH (HKEx), AKEBIA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), CKLIFE SCIENCES (HKEx), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MESOBLAST LTD (ASX), NEXT SCIENCE LTD (ASX), AVITA MEDICAL LTD (ASX), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MEDICINOVA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), LEE'S PHARM (HKEx), PROTHENA CORP PLC (NASDAQ), AGENUS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), NEXTCURE INC (NASDAQ), RESTORBIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), AVROBIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), MERUS B V (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MANNKIND CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), KADMON HLDGS INC (NYSE), KAMADA (NASDAQ), DPHARMA (Bursa), PIERIS PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), COMPUGEN (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), RECRO PHARMA INC (NASDAQ), ENZO BIOCHEM INC (NYSE), AFFIMED N V (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), SOLID BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PFENEX INC (NYSE American), IMV INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ARDELYX INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), BBI LIFE SCI (HKEx), ADURO BIOTECH INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), TELIX PHARMACEUTIC (ASX), XOMA CORP (NASDAQ), SESEN BIO INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), TOCAGEN INC (NASDAQ), VERASTEM INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), INMUNE BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NANTKWEST INC (NASDAQ), TREVENA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), UNI-BIO GROUP (HKEx), ITERUM THERAPEUTICS PLC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INFLARX N V (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), SAVARA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), PORT (SET), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), T2 BIOSYSTEMS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), IBIO INC (NYSE American), OTONOMY INC (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VERMILLION INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ORGENESIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ARAVIVE INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), VACCINEX INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), REGENT PACIFIC (HKEx), CEL-SCI CORP (NYSE American), NEWLINK GENETICS CORP (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CT ENTERPRISE (HKEx), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), IVERIC BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CURIS INC (NASDAQ), ORTHOCELL LIMITED (ASX), SEELOS THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), PHYLOGICA LIMITED (ASX), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), EVOGENE LTD (NASDAQ), CONTRAFECT CORP (NASDAQ), IMUGENE LIMITED (ASX), SENESTECH INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CELLDEX THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), EXTRAWELL PHAR (HKEx), BIONANO GENOMICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), BIOTRON (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HEAT BIOLOGICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), BIOSINO BIO-TEC (HKEx), ONCOLYTICS BIOTECH INC (NASDAQ), ORAGENICS INC (NYSE American), CONATUS PHARMACEUTICALS INC (NASDAQ), ISORAY INC (NYSE American), RHINOMED LIMITED (ASX), ZELDA THERAPEUTICS LTD (ASX), AEVI GENOMIC MEDIC (NASDAQ), BIONOMICS LTD (ASX), HISTOGENICS CORP (NASDAQ), INSYS THERAPEUTICS INC (NASDAQ), COLLPLANT HOLDINGS LTD SPON ADR EACH REP 50 ORD(POST REV SPLT) (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), VICAL INC (NASDAQ), BIOCEPT INC (NASDAQ), PATRYS LIMITED (ASX), PRECIPIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), ADVAXIS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), NANOVIRICIDES INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), TROVAGENE INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), REGENEUS LTD (ASX), IMMURON LIMITED (ASX), CAPRICOR THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), CONTANGO ASSET MANAGEMENT LIMITED (ASX), VAXART INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), CELLMID LIMITED (ASX), OHR PHARMACEUTICAL INC (NASDAQ), MEMPHASYS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PHIO PHARMACEUTICALS CORP (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), BIOXYNE LIMITED (ASX), MGRC (Bursa), OPGEN INC (NASDAQ), NEURALSTEM INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), MEGASUN (Bursa), ACTINOGEN MEDICAL LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CYTORI THERAPEUTICS INC (NASDAQ), NOVITA HEALTHCARE LTD (ASX), TBG DIAGNOSTICS LTD (ASX), CCP TECHNOLOGIES LTD (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NANOLLOSE LTD (ASX), TRILLIUM THERAPEUTICS INC (NASDAQ), BPH ENERGY LIMITED (ASX), MEDIBIO LIMITED (ASX), ALCHEMIA LIMITED (ASX), SINOVAC BIOTECH (NASDAQ), GENERA BIOSYSTEMS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.001
-25.00 %
10 Days ---
20 Days --0.001
-25.00 %
Medium Term Return 3 Months --0.004
-57.14 %
6 Months --0.005
-62.50 %
1 Year --0.009
-75.00 %
Long Term Return 2 Years --0.027
-90.00 %
3 Years --0.084
-96.55 %
5 Years --0.532
-99.44 %
Annualised Return Annualised --
-64.54 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.003 - 0.014 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High -0.011 % Change From 1 Year High (%) -78.57
2 Years Range 0.003 - 0.030 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High -0.027 % Change From 2 Years High (%) -90.00
5 Years Range 0.003 - 0.545 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -0.542 % Change From 5 Years High (%) -99.45
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

IPO Performance

Listing Date 29 Apr 2014 Full Subscription Rate (x) -
No of Placement Shares (M) 196.43 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.340 First Week Close (SGD) 0.345
Current vs IPO Price (%) -98.93 First Day Gain (%) +21.43 First Week Gain (%) +23.21

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(1.05 MB)
Part 2(0.10 MB)
Annual Report 2017 Dec 2017 Part 1(0.91 MB)
Part 2(0.08 MB)
Annual Report 2016 Dec 2016 Part 1(1.60 MB)
Part 2(0.47 MB)
Annual Report 2015 Dec 2015 Part 1(0.82 MB)
Part 2(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(2.05 MB)
Part 2(0.42 MB)
Annual Report 2013 Dec 2013 Part 1(1.04 MB)
IPO Prospectus
IPO Prospectus 2014 Apr 2014 Part 1(3.55 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
18 Jun 2019 0.003 0.003 0.003 0.003 1,000,000 0.0030
17 Jun 2019 0.003 0.003 0.003 0.003 55,000 0.0030
14 Jun 2019 0.003 0.003 0.003 0.003 - -
13 Jun 2019 0.004 0.004 0.003 0.003 56,000 0.0038
12 Jun 2019 0.004 0.004 0.004 0.004 - -
11 Jun 2019 0.004 0.004 0.004 0.004 200,000 0.0040
10 Jun 2019 0.003 0.004 0.003 0.004 600,000 0.0035
07 Jun 2019 0.003 0.003 0.003 0.003 370,000 0.0030
06 Jun 2019 0.003 0.003 0.003 0.003 110,000 0.0030
04 Jun 2019 0.003 0.003 0.003 0.003 - -
03 Jun 2019 0.003 0.003 0.003 0.003 11,645,900 0.0030
31 May 2019 0.003 0.003 0.003 0.003 197,000 0.0030
30 May 2019 0.003 0.003 0.003 0.003 - -
29 May 2019 0.003 0.003 0.003 0.003 - -
28 May 2019 0.003 0.003 0.003 0.003 1,389,700 0.0030
27 May 2019 0.003 0.003 0.003 0.003 6,442,200 0.0030
24 May 2019 0.003 0.003 0.003 0.003 610,000 0.0030
23 May 2019 0.004 0.004 0.003 0.003 850,000 0.0034
22 May 2019 0.003 0.003 0.003 0.003 900,000 0.0030
21 May 2019 0.004 0.004 0.004 0.004 350,000 0.0040
17 May 2019 0.004 0.004 0.004 0.004 - -
16 May 2019 0.004 0.004 0.004 0.004 - -
Summary
Current 2 Weeks
(04 Jun 2019 to 18 Jun 2019)
0.003 0.004 0.003 0.003 2,391,000 -
Previous 2 Weeks
(21 May 2019 to 03 Jun 2019)
0.004 0.004 0.003 0.003 22,384,800 -
4 Weeks from
(18 Apr 2019 to 17 May 2019)
0.004 0.004 0.003 0.004 30,259,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.